Suchergebnisse - "Sarilumab"

PubPharm (15)

1

Effectiveness and safety of sarilumab in patients with rheumatoid arthritis : A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

enthalten in: Clinical rheumatology | 2024

von Harada, H. | Kondo, M. | Maeyama, A. | +8

ErratumIn: Clin Rheumatol. 2024 Mar 15;:. - PMID 38489137

2

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

3

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis : results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis research & therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

4

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis : the ANSWER cohort study

enthalten in: Clinical rheumatology | 2021

von Ebina, K. | Hirano, T. | Maeda, Y. | +16

5

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes : post hoc analyses of three randomised, controlled trials

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Burmester, G. | Hagino, O. | +6

6

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Fleischmann, R. | Kivitz, A. | +6

7

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

enthalten in: Arthritis Research & Therapy | 2020

von Genovese, M. | Fleischmann, R. | Kivitz, A. | +6

8

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

enthalten in: Arthritis Research & Therapy | 2020

von Genovese, M. | Fleischmann, R. | Kivitz, A. | +6

9

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

in: Arthritis Research & Therapy | 2020

von Mark C. Genovese | Roy Fleischmann | Alan Kivitz | +6

10

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5